CRM197 is a non-toxic mutant of diphtheria toxin and it"s widely used as a carrier protein for conjugate vaccines.
According to our (Global Info Research) latest study, the global CRM197 market size was valued at US$ 182 million in 2023 and is forecast to a readjusted size of USD 258 million by 2030 with a CAGR of 5.1% during review period.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
This report is a detailed and comprehensive analysis for global CRM197 market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global CRM197 market size and forecasts, in consumption value ($ Million), 2019-2030
Global CRM197 market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global CRM197 market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global CRM197 market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for CRM197
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global CRM197 market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Ligand Pharmaceuticals, CanSino Biologic, Beijing Kexing Biology Product, Scarab Genomics, Xpress Biologics, Fina Biosolutions, Eubiologics, EirGenix Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
CRM197 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
CRM197 market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Research Grade CRM197
cGMP Grade CRM197
Market segment by Application
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
Market segment by players, this report covers
Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CRM197 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CRM197, with revenue, gross margin, and global market share of CRM197 from 2019 to 2024.
Chapter 3, the CRM197 competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CRM197 market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CRM197.
Chapter 13, to describe CRM197 research findings and conclusion.
Summary:
Get latest Market Research Reports on CRM197. Industry analysis & Market Report on CRM197 is a syndicated market report, published as Global CRM197 Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of CRM197 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.